Shuyuan Cheng
-
- Immune cells in cancer 2
-
- Epigenetics and DNA Methylation 2
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
- Receptor Mechanisms and Signaling 2
-
- Acute Myeloid Leukemia Research 3
-
- Plant-Microbe Interactions and Immunity 2
- Plant Pathogenic Bacteria Studies 2
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Acta Pharmaceutica Sinica B (1 paper)Brain Research (1 paper)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Shuyuan Cheng
14 papers receiving 484 citations
Peers
Comparison fields: 5 of 68
- Cellular and Molecular Neuroscience 130
- Aging 9
- Immunology 89
- Oncology 101
- Molecular Biology 248
Countries citing papers authored by Shuyuan Cheng
This map shows the geographic impact of Shuyuan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyuan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyuan Cheng more than expected).
Fields of papers citing papers by Shuyuan Cheng
This network shows the impact of papers produced by Shuyuan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyuan Cheng. The network helps show where Shuyuan Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuyuan Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 34 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 16 | |
| 8 | 2019 | 148 | |
| 9 | 2019 | 2 | |
| 10 | 2018 | 48 | |
| 11 | 2010 | 23 | |
| 12 | 2009 | 148 | |
| 13 | 2007 | 14 | |
| 14 | 2006 | 37 |
About Shuyuan Cheng
Shuyuan Cheng is a scholar working on Hematology, Cellular and Molecular Neuroscience and Cell Biology, having authored 14 papers that have together received 487 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Plant-Microbe Interactions and Immunity (2 papers), Epigenetics and DNA Methylation (2 papers), Protein Degradation and Inhibitors (2 papers), Plant Pathogenic Bacteria Studies (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Immune cells in cancer (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (130 citations), Aging (9 citations) and Immunology (89 citations). Shuyuan Cheng has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Bo Yang, Xi Chen, Qiaojun He, Ling Ding, Xiaohui Pan, Wenxin Zhang, Hongjie Guo, Maarten E. A. Reith, Esther L. Sabban and Volodia D. Gueorguiev. Their work appears in journals such as Biochemical and Biophysical Research Communications, Acta Pharmaceutica Sinica B, Brain Research, Nature Communications and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.